Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Asterand and 5AM Solutions Enter a Preferred Partnership Agreement

Asterand plc
Posted on: 29 Mar 11

Asterand plc (LSE:ATD), a leading provider of human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, and 5AM Solutions, a life science technology firm, today announce that they have entered into an agreement to develop next generation virtual biobanking software for exclusive use by Asterand and its collaborators. The aim of the project is to enable broad access to geographically distinct biospecimen resources in an easy to use manner, thereby accelerating discovery in human disease research.

The companies will share development costs to build software providing a standardized solution for the identification, annotation and distribution of human biological materials for use in research. Asterand and 5AM will electronically link disparate biobanks to Asterand’s centralized biobanking operations in Detroit, MI. The proprietary software will enable Asterand to garner biospecimen and data requirements from researchers and query partner biobanks for appropriate specimens. Once identified, specimens will be selected and qualified for distribution by Asterand.

“We are delighted to enter this partnership with 5AM,” noted Dr. Victoria Blanc, Asterand’s Vice President of Strategic Planning and Government Affairs. “Our customers require large numbers of highly annotated biological specimens. We believe that this software will assist us to meet this demand by allowing us to have vision into an ever-increasing network of sophisticated biobanks. 5AM Solutions has a proven track record of delivering scientifically driven software solutions to meet the needs of researchers across sectors.”

“We are thrilled to be working with Asterand on this novel endeavor,” Brent Gendleman, Chief Executive Officer at 5AM Solutions added. “Asterand has a global reach and a critical mission to expand access to high quality human tissue. They are the perfect partner to assist us in our goal to revolutionize the way scientists acquire biospecimens and data needed to decrease the timeline for meaningful results. Together we will create the platform required to link distant biorepositories into a virtual bank and enable controlled access to specimens for research.”

About ASTERAND

Asterand plc is a leading supplier of high quality human tissue and tissue-based services. Our comprehensive approach to human tissue and research services offers pharmaceutical, biotech and diagnostic companies the unique opportunity to have one company meet all of their human biomaterial needs along the continuum of drug discovery and development. Our mission is to accelerate target discovery and compound validation and enable pharmaceutical and biotechnology companies to take safer and more effective drugs into the market.

For more information, go to www.Asterand.com.

About 5AM Solutions

5AM Solutions develops innovative software solutions for life science professionals. The company helps evolve the way biomedical researchers work and collaborate by using software to reveal new insights hidden in vast amounts of data, facilitate translational research, and solve workflow challenges. The company’s solutions overcome IT-based roadblocks to discovery and accelerate progress toward the ultimate goal of better health and improved patient outcomes.

For more information, go to www.5amsolutions.com.

Business Wire
http://www.businesswire.com/

Last updated on: 29/03/2011

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.